<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05099991</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-63172</org_study_id>
    <nct_id>NCT05099991</nct_id>
  </id_info>
  <brief_title>Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion</brief_title>
  <official_title>Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion: a Non-Inferiority Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a Foley balloon is similar to osmotic&#xD;
      dilators for preparing the cervix prior to a second trimester abortion. Procedure time will&#xD;
      be used to compare the two different methods of cervical preparation, reflecting the ease at&#xD;
      which the surgeon can perform through a prepared cervix. The aim is to expand effective&#xD;
      options for cervical preparation that will can accommodate for varying patient&#xD;
      characteristics and provider experiences.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure time</measure>
    <time_frame>Approximately 12 minutes</time_frame>
    <description>Time to speculum in to speculum out</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cervical dilation</measure>
    <time_frame>Beginning of the procedure (approximately 5 seconds to assess)</time_frame>
    <description>Measure the cervical dilation after removal of the Foley balloon or Dilapan-S</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Abortion, Second Trimester</condition>
  <arm_group>
    <arm_group_label>Dilapan-S</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A number of Dilapan-S will be inserted for cervical preparation. The number will be determined by a standard protocol that is based on gestational age. The dilators will stay in until the next day prior to their procedure, or earlier if they fall out on their own.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foley balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Foley balloon will be inserted for cervical preparation and filled to 30mL of water or saline. The balloon will stay in until the next day prior to their procedure, or earlier if it falls out on its own.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single Foley Balloon</intervention_name>
    <description>Foley Balloon will be placed through the cervix and inflated with 30mL of saline or water on the day prior to the procedure</description>
    <arm_group_label>Foley balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan-S</intervention_name>
    <description>Dilapan S will be placed through the cervix on the day prior to the procedure</description>
    <arm_group_label>Dilapan-S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  presenting to clinic for second trimester abortion at 18 to 23 weeks and 6 days&#xD;
             gestation confirmed by ultrasound&#xD;
&#xD;
          -  able to provide informed consent and comply with study protocol&#xD;
&#xD;
          -  English or Spanish-speaking&#xD;
&#xD;
          -  candidate for outpatient cervical preparation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anyone with an allergy to misoprostol, mifepristone or any study medication&#xD;
&#xD;
          -  premature rupture of membranes&#xD;
&#xD;
          -  intrauterine fetal demise&#xD;
&#xD;
          -  placenta previa&#xD;
&#xD;
          -  suspected abnormal placentation&#xD;
&#xD;
          -  evidence of infection at the time of enrollment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 17, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

